Combo Product Industry Coalition Proposal Elevates Post-Approval Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
Genzyme, Roche, Guidant are among the firms represented by the Combination Product Coalition to focus on improving post-approval regulatory pathways, such as modifications and cross-labeling for “virtual” combo products.
You may also be interested in...
FDA Combo Product Final Rule Adds "Intended" Use To Primary Mode Of Action Definition
Final rule includes an algorithm for the Office of Combination Products to use if primary mode of action cannot be established.
ICMJE Clinical Trial Registration Criteria Could Exempt High-Risk Medical Devices, Says IoM Report
The Institute’s Board on Health Sciences Policy is preparing a clinical trials registry for fall release.